Stifel Financial’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.02M Buy
454,019
+52,237
+13% +$808K 0.01% 1068
2025
Q1
$5.97M Sell
401,782
-33,359
-8% -$496K 0.01% 1092
2024
Q4
$5.76M Sell
435,141
-5,525
-1% -$73.2K 0.01% 1132
2024
Q3
$6.27M Buy
440,666
+224,594
+104% +$3.19M 0.01% 1077
2024
Q2
$2.8M Sell
216,072
-78,143
-27% -$1.01M ﹤0.01% 1496
2024
Q1
$4.09M Buy
294,215
+85,772
+41% +$1.19M ﹤0.01% 1258
2023
Q4
$2.97M Sell
208,443
-85,370
-29% -$1.22M ﹤0.01% 1409
2023
Q3
$4.55M Buy
293,813
+14,766
+5% +$228K 0.01% 1078
2023
Q2
$4.38M Buy
279,047
+3,859
+1% +$60.6K 0.01% 1118
2023
Q1
$4.54M Buy
275,188
+161,919
+143% +$2.67M 0.01% 1084
2022
Q4
$1.77M Sell
113,269
-10,428
-8% -$163K ﹤0.01% 1608
2022
Q3
$1.6M Buy
123,697
+15,182
+14% +$197K ﹤0.01% 1622
2022
Q2
$1.52M Buy
108,515
+12,679
+13% +$178K ﹤0.01% 1687
2022
Q1
$1.37M Buy
95,836
+8,884
+10% +$127K ﹤0.01% 1891
2021
Q4
$1.19M Buy
86,952
+10,212
+13% +$139K ﹤0.01% 1994
2021
Q3
$1.26M Buy
76,740
+12,178
+19% +$199K ﹤0.01% 1908
2021
Q2
$1.09M Buy
64,562
+383
+0.6% +$6.44K ﹤0.01% 2032
2021
Q1
$1.17M Sell
64,179
-93,125
-59% -$1.7M ﹤0.01% 1889
2020
Q4
$2.86M Sell
157,304
-43,185
-22% -$786K 0.01% 1163
2020
Q3
$3.58M Sell
200,489
-4,117
-2% -$73.5K 0.01% 926
2020
Q2
$3.67M Sell
204,606
-14,059
-6% -$252K 0.01% 861
2020
Q1
$3.32M Buy
218,665
+2,851
+1% +$43.3K 0.01% 820
2019
Q4
$4.26M Buy
215,814
+25,649
+13% +$506K 0.01% 956
2019
Q3
$3.27M Sell
190,165
-17,891
-9% -$308K 0.01% 1026
2019
Q2
$3.68M Buy
208,056
+6,538
+3% +$116K 0.01% 987
2019
Q1
$4.1M Buy
+201,518
New +$4.1M 0.01% 893